A.N.B. Laboratories
↗Bangkok, Thailand
A.N.B. Laboratories is a leading Thai pharmaceutical manufacturer specializing in the production of sterile products, including large-volume parenterals (IV fluids), small-volume parenterals, and ophthalmic preparations. Established in 1955, the company has grown to become one of the largest suppliers of hospital-grade fluids and injectable medicines in Southeast Asia.
The company operates as a critical manufacturing subsidiary of Bangkok Dusit Medical Services (BDMS), Thailand's largest private hospital network. A.N.B. Laboratories maintains high-standard manufacturing facilities certified by GMP (PIC/S), ISO 9001, and ISO 17025, exporting its products to over 20 countries across Asia, Africa, and the Middle East.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Sterile Injectables & Generic Manufacturing
SIZE & FINANCIALS
Employees:501-1000
Revenue:$50M-$100M
Founded:1955
Ownership:subsidiary
Status:operating
FUNDING
Investors:Bangkok Dusit Medical Services (BDMS)
STOCK
Exchange:SET
Ticker:BDMS
Market Cap:$12.5B (Parent Company)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Sterile Liquids, Injectables
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Bangkok Dusit Medical Services (BDMS)
Acquired By:Bangkok Dusit Medical Services (BDMS) (2013-01-01)
Key Partnerships:Save Drug Center (Retail distribution), Ministry of Public Health Thailand, Various international distributors in ASEAN
COMPETITION
Position:Leader
Competitors:Thai Nakorn Patana, General Hospital Products (GHP), Siam Pharmaceutical, B. Braun Thailand
LEADERSHIP
Key Executives:
Somsak Chunharas - Managing Director
Praphon Tangsuan - AVP - IT
Board Members:Poramaporn Prasarttong-Osoth
LINKS
Website:anblab.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with A.N.B. Laboratories. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.